Literature DB >> 18283526

Negative predictive value of D-dimer for diagnosis of venous thromboembolism.

Hideki Nomura1, Hideo Wada, Toshiro Mizuno, Naoyuki Katayama, Yasunori Abe, Maki Noda, Kaname Nakatani, Takeshi Matsumoto, Satoshi Ota, Norikazu Yamada, Akihiro Sudo, Atsumasa Uchida, Tsutomu Nobori.   

Abstract

The D-dimer levels are considered to be useful for the diagnosis of thrombosis, and they can be clinically used as a negative predictive value (NPV). However, evidence for the efficacy of diagnosing thrombosis based on the D-dimer levels is still not well established. The present study was designed to evaluate the cut-off values of D-dimer levels as a negative predictor for thrombosis. The plasma concentrations of D-dimer were measured in inpatients suspected of having thrombosis, and then the findings were evaluated to assess the correlation with the diagnosis of thrombosis. In healthy volunteers, the median value of VIDAS-D-dimer was 0.12 microg/ml, and the 95% confidence interval was from 0.05 to 0.38 microg/ml. However, the plasma D-dimer levels were significantly higher in patients with thrombosis than in those without thrombosis; there was no significant difference in D-dimer levels among various thromboses such as pulmonary embolism (PE), deep vein thrombosis (DVT), and disseminated intravascular coagulation (DIC). The NPV for venous thromboembolism was 100% in patients with 0.5 microg/ml VIDAS-D-dimer and 1.2 microg/ml LPIA-D-dimer levels. Elevated D-dimer levels might indicate a high risk of thrombosis, especially DVT/PE, and they are thus considered to be useful as a negative predictor for thrombosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18283526     DOI: 10.1007/s12185-008-0047-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  31 in total

Review 1.  The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.

Authors:  C E Dempfle
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

2.  Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale.

Authors:  E Oger
Journal:  Thromb Haemost       Date:  2000-05       Impact factor: 5.249

3.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

Review 4.  Clinical practice. The evaluation of suspected pulmonary embolism.

Authors:  Peter F Fedullo; Victor F Tapson
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

5.  Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.

Authors:  H Wada; N Sakuragawa; H Shiku
Journal:  Semin Thromb Hemost       Date:  1998       Impact factor: 4.180

6.  Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease.

Authors:  Y Saito; H Wada; M Yamamuro; A Inoue; M Shimura; K Hiyoyama; E C Gabazza; N Isaka; H Shiku; H Takeya; K Suzuki; K Kumeda; H Kato; T Nakano
Journal:  Am J Hematol       Date:  1999-08       Impact factor: 10.047

Review 7.  Disseminated intravascular coagulation.

Authors:  Hideo Wada
Journal:  Clin Chim Acta       Date:  2004-06       Impact factor: 3.786

8.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

9.  Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia.

Authors:  H Wada; Y Mori; T Kaneko; Y Wakita; T Nakase; K Minamikawa; M Ohiwa; S Tamaki; M Tanigawa; S Kageyama
Journal:  Am J Hematol       Date:  1993-10       Impact factor: 10.047

10.  Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.

Authors:  H Wada; T Kaneko; M Ohiwa; M Tanigawa; T Hayashi; S Tamaki; N Minami; K Deguchi; K Suzuki; T Nakano
Journal:  Am J Hematol       Date:  1993-10       Impact factor: 10.047

View more
  22 in total

1.  Should the cut-off value of D-dimer be elevated to exclude pulmonary embolism in acute exacerbation of COPD?

Authors:  Evrim Eylem Akpinar; Derya Hoşgün; Beyza Doğanay; Gökçe Kaan Ataç; Meral Gülhan
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery.

Authors:  Akihiro Sudo; Hideo Wada; Tsutomu Nobori; Norikazu Yamada; Masaaki Ito; Rui Niimi; Masahiro Hasegawa; Koji Suzuki; Atsumasa Uchida
Journal:  Int J Hematol       Date:  2009-05-09       Impact factor: 2.490

3.  The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE.

Authors:  Masahiro Hasegawa; Hideo Wada; Toshio Yamaguchi; Hiroki Wakabayashi; Naoki Fujimoto; Takeshi Matsumoto; Kei Hasegawa; Norikazu Yamada; Masaaki Ito; Yoshiki Yamashita; Naoyuki Katayama; Kaname Nakatani; Akihiro Sudo
Journal:  Clin Appl Thromb Hemost       Date:  2017-05-08       Impact factor: 2.389

4.  Evaluation of D-Dimer in Screening Deep Vein Thrombosis in Hospitalized Japanese Patients with Acute Medical Diseases/Episodes.

Authors:  Hiroshi Matsuo; Yoshie Nakajima; Tomohiro Ogawa; Makoto Mo; Junichi Tazaki; Takahiro Doi; Norikazu Yamada; Takeo Suzuki; Hiromu Nakajima
Journal:  Ann Vasc Dis       Date:  2016-07-19

5.  Fibrin-related markers for diagnosing acute-, subclinical-, and pre-venous thromboembolism in patients with major orthopedic surgery.

Authors:  Toshio Yamaguchi; Hideo Wada; Shinichi Miyazaki; Masahiro Hasegawa; Hiroki Wakabayashi; Kunihiro Asanuma; Naoki Fujimoto; Takeshi Matsumoto; Kohshi Ohishi; Akane Sakaguchi; Norikazu Yamada; Masaaki Ito; Yoshiki Yamashita; Naoyuki Katayama; Akihiro Sudo
Journal:  Int J Hematol       Date:  2016-02-12       Impact factor: 2.490

6.  Significance of plasma D-dimer in relation to the severity of atherosclerosis among patients evaluated by non-invasive indices of cardio-ankle vascular index and carotid intima-media thickness.

Authors:  Shigeru Hayashi
Journal:  Int J Hematol       Date:  2010-06-18       Impact factor: 2.490

7.  The Evaluation of Fibrin-Related Markers for Diagnosing or Predicting Acute or Subclinical Venous Thromboembolism in Patients Undergoing Major Orthopedic Surgery.

Authors:  Masahiro Hasegawa; Hideo Wada; Shinichi Miyazaki; Toshio Yamaguchi; Hiroki Wakabayashi; Naoki Fujimoto; Takeshi Matsumoto; Kohshi Ohishi; Akane Sakaguchi; Norikazu Yamada; Masaaki Ito; Yoshiki Yamashita; Naoyuki Katayama; Kaname Nakatani; Akihiro Sudo
Journal:  Clin Appl Thromb Hemost       Date:  2016-10-21       Impact factor: 2.389

8.  Elevated preoperative plasma D-dimer levels and the incidence of venous thromboembolism in Japanese females with gynecological cancer.

Authors:  Junichi Kodama; Noriko Seki; Chikako Fukushima; Tomoyuki Kusumoto; Keiichiro Nakamura; Atsushi Hongo; Yuji Hiramatsu
Journal:  Oncol Lett       Date:  2012-10-15       Impact factor: 2.967

9.  Elevated levels of soluble fibrin in patients with venous thromboembolism.

Authors:  Akihiro Tsuji; Hideo Wada; Takeshi Matsumoto; Yasunori Abe; Satoshi Ota; Norikazu Yamada; Takashi Sugiyama; Akihiro Sudo; Katsuya Onishi; Kaname Nakatani; Atsumasa Uchida; Masaaki Ito; Koji Suzuki; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-10-04       Impact factor: 2.490

10.  Prothrombin time-international normalized ratio is a useful marker for edoxaban efficacy in preventing venous thromboembolism after total knee arthroplasty.

Authors:  Kazuki Kodato; Kazunari Ishida; Nao Shibanuma; Akihiko Toda; Koji Takayama; Shinya Oka; Shinya Hayashi; Shingo Hashimoto; Masahiro Kurosaka; Ryosuke Kuroda; Tomoyuki Matsumoto
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.